Mirae Asset Global Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Mirae Asset Global Investments’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-204,430	Closed	-$4.12M	–	1817
2021 Q3	$4.12M	Buy	204,430 +39,179	+24%	+$1.08M	0.01%	904
2021 Q2	$6.17M	Buy	165,251 +18,664	+13%	+$572K	0.02%	766
2021 Q1	$3.75M	Buy	146,587 +66,432	+83%	+$1.7M	0.01%	795
2020 Q4	$1.77M	Buy	80,155 +22,351	+39%	+$492K	0.01%	966
2020 Q3	$1.04M	Buy	57,804 +18,089	+46%	+$375K	0.01%	957
2020 Q2	$1.01M	Buy	39,715 +17,910	+82%	+$386K	0.01%	903
2020 Q1	$401K	Buy	21,805 +2,363	+12%	+$45.9K	﹤0.01%	1096
2019 Q4	$428K	Buy	19,442 +3,250	+20%	+$65.4K	﹤0.01%	1264
2019 Q3	$233K	Buy	+16,192	New	+$231K	﹤0.01%	1356

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Mirae Asset Global Investments's DRNA Position: Q4 2021 in Review

Mirae Asset Global Investments sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 204,430 shares — an estimated $4.12M sold.

Mirae Asset Global Investments first reported a position in DRNA in Q3 2019 and held it in 9 quarters. The position peaked at $6.17M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Mirae Asset Global Investments reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Mirae Asset Global Investments sold 204,430 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4.12M.
Mirae Asset Global Investments first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2019 and held it in 9 quarters.
Mirae Asset Global Investments's Dicerna Pharmaceuticals, Inc. position peaked at $6.17M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Mirae Asset Global Investments's 13F filing for Q4 2021, filed 8 Feb 2022.